Back

When should prolonged antiplatelet regimens be considered?

26 August 2023 (14:45 - 15:00)
Organised by: Logo
Congress Presentation Part of: Oral antiplatelet therapy after acute coronary syndromes: how to choose the best regimen and the optimum duration Acute Coronary Syndromes ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sergio Tavares Montenegro

Procape, Recife (Brazil)

3 More presentations in this session

Presentation thumbnail
Antiplatelet monotherapy in acute coronary syndromes: which patients and when
Professor P. Lemos (Sao Paulo, BR)
Slides Video
Presentation thumbnail
Is prasugrel preferred over ticagrelor?
Professor A. Kastrati (Munich, DE)
Slides Video
Presentation thumbnail
Oral anticoagulant therapy with antiplatelet therapy: what is evidence-based practice?
Doctor R. Colleran (Dublin 7, IE)
Slides Video

Access the full session

Session thumbnail
Oral antiplatelet therapy after acute coronary syndromes: how to choose the best regimen and the optimum duration
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 14:45 CET
You may be interested in
thumbnail
Congress Presentation
Extended, standard or de-escalation antiplatelet therapy after ACS?
18 March 2022
thumbnail
Congress Presentation
When and how to escalate antithrombotic therapy beyond aspirin in chronic coronary syndromes
2 September 2024
thumbnail
Congress Session
Optimal antithrombotic regimen after percutaneous coronary intervention in stable coronary artery disease
26 August 2023
thumbnail
Congress Presentation
When should we prolong DAPT beyond 12 months?
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources